ASND icon

Ascendis Pharma

241 hedge funds and large institutions have $10.1B invested in Ascendis Pharma in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 76 increasing their positions, 87 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
+30
Holders Change %
+14.22%
% of All Funds
3.27%
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
54
Increased
76
Reduced
87
Closed
22
Calls
$23.8M
Puts
$38.3M
Net Calls
-$14.5M
Net Calls Change
+$6.32M
Name Holding Trade Value Shares
Change
Shares
Change %
Cambridge Investment Research Advisors
251
Cambridge Investment Research Advisors
Iowa
-$689K -5,007 Closed
Verition Fund Management
252
Verition Fund Management
Connecticut
-$592K -4,300 Closed
LP
253
LMR Partners
United Kingdom
-$427K -3,100 Closed
VEA
254
Virtus ETF Advisers
New York
-$368K -2,676 Closed
GCP
255
GSA Capital Partners
United Kingdom
-$236K -1,717 Closed
MML Investors Services
256
MML Investors Services
Massachusetts
-$226K -1,644 Closed
T
257
TOBAM
France
-$223K -1,622 Closed
BC
258
Bayforest Capital
United Kingdom
-$160K -1,165 Closed
PAS
259
Point72 Asia (Singapore)
Singapore
-$27.9K -202 Closed
CAS
260
Coppell Advisory Solutions
Texas
-$19.2K -141 Closed
EC
261
Elequin Capital
New York
-$7.3K -53 Closed
EBA
262
Eagle Bay Advisors
New York
-$3.2K -23 Closed
AF
263
Allworth Financial
California
-$252 -2 Closed
IA
264
IFP Advisors
Florida
-$138 -1 Closed